XML 45 R27.htm IDEA: XBRL DOCUMENT v3.6.0.2
Stock-based Compensation (Tables)
12 Months Ended
Dec. 31, 2016
Stock-based Compensation  
Summary of stock option activity

                                                                                                                                                                                    

 

 

 

 

 

 

Weighted Average

 

 

 

 

 

Weighted
Average
Exercise
Price

 

 

 

Number of
Shares

 

Remaining
Contractual
Life (Years)

 

Aggregate
Intrinsic
Value

 

Outstanding at December 31, 2015

 

 

1,748,875

 

$

15.04

 

 

9.38

 

$

8,224,947

 

Granted

 

 

973,638

 

$

33.10

 

 

 

 

 

 

 

Exercised

 

 

(84,127

)

$

5.11

 

 

 

 

 

 

 

Cancelled or forfeited

 

 

(61,275

)

$

22.19

 

 

 

 

 

 

 

​  

​  

Outstanding at December 31, 2016

 

 

2,577,111

 

$

22.01

 

 

8.79

 

$

66,466,245

 

​  

​  

​  

​  

Exercisable at December 31, 2015

 

 

168,360

 

$

2.47

 

 

8.41

 

$

2,907,260

 

​  

​  

​  

​  

Vested at December 31, 2015 and expected to vest

 

 

1,668,837

 

$

15.64

 

 

9.42

 

$

6,842,807

 

​  

​  

​  

​  

Exercisable at December 31, 2016

 

 

704,111

 

$

14.86

 

 

8.42

 

$

23,146,606

 

​  

​  

​  

​  

Vested and expected to vest at December 31, 2016

 

 

2,577,111

 

$

22.01

 

 

8.79

 

$

66,466,245

 

​  

​  

​  

​  


 

 

 

(a)          

The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the estimated fair value of the common stock for the options that were in-the-money at December 31, 2015 and 2016.

 

Summary of aggregate stock-based compensation recorded in consolidated statements of operations and comprehensive loss

                                                                                                                                                                                    

 

 

Year ended
December 31,
2016

 

Year ended
December 31,
2015

 

Year ended
December 31,
2014

 

Research and development

 

$

5,988,231 

 

$

1,293,841 

 

$

179,641 

 

General and administrative

 

 

9,668,141 

 

 

3,956,376 

 

 

236,983 

 

​  

​  

​  

​  

​  

​  

 

 

$

15,656,372 

 

$

5,250,217 

 

$

416,624 

 

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

 

Summary of grant date fair value and assumptions used in determining fair value of stock options

                                                                                                                                                                                    

 

 

Year ended
December 31,
2016

 

Year ended
December 31,
2015

 

Year ended
December 31,
2014

 

Expected volatility

 

 

91.84 

%

 

90.00 

%

 

86.94 

%

Risk-free interest rate

 

 

1.45 

%

 

1.57 

%

 

1.16 

%

Expected term (in years)

 

 

6.08 

 

 

6.08 

 

 

4.19 

 

Expected dividend yield

 

 

0.00 

%

 

0.00 

%

 

0.00 

%

 

Summary of restricted stock units activity

                                                                                                                                                                                    

 

 

Number
of Shares

 

Weighted Average
Grant Date
Fair Value
Per Share

 

Outstanding at December 31, 2015

 

 

 

$

 

Granted

 

 

57,500 

 

 

34.90 

 

Vested

 

 

 

 

 

Forfeited and cancelled

 

 

 

 

 

​  

​  

Outstanding at December 31, 2016

 

 

57,500 

 

$

34.90 

 

​  

​  

​  

​  

 

Summary of restricted stock activity

                                                                                                                                                                                    

 

 

Number of
common shares

 

Nonvested shares at December 31, 2015

 

 

1,750,794 

 

Shares granted

 

 

 

Shares vested

 

 

1,750,794 

 

​  

​  

Nonvested shares at December 31, 2016

 

 

 

​  

​  

​  

​